fifteen vimentin-positive tumors were subdivided into malignant melanomas with the use of antibody to s-100 protein , lymphomas with the use of antibody to immunoglobulin , and mesenchymal tumors ( angiosarcomas , atypical fibroxanthomas , dermatofibrosarcoma protuberans , and meningiomas ) with the use of antibody to s-100 protein , factor viii , and lysozyme .
C0003241
antibody
C0021027
immunoglobulin